Basiliximab for the Treatment of Steroid Refractory Acute Graft-Versus-Host-Disease Following Allogeneic Stem Cell Transplantation

被引：1
|
作者：
Mahmoudjafari, Zahra [1 ]
McGuirk, Joseph [2 ]
Ganguly, Siddhartha [3 ]
Aljitawi, Omar [2 ]
Lin, Tara L. [2 ]
Singh, Anurag K. [2 ]
Shune, Leyla [2 ]
Abhyankar, Sunil [2 ]
机构：
[1] Univ Kansas, Med Ctr, Dept Pharm, Westwood, KS USA
[2] Univ Kansas, Med Ctr, Blood & Marrow Transplant, Westwood, KS USA
[3] Univ Kansas, Med Ctr, Hematol Malignancies & Cellular Therapeut, Westwood, KS USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2016年 / 22卷 / 03期
关键词：
D O I：
10.1016/j.bbmt.2015.11.1092
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
754
引用
收藏
页码：S476 / S477
页数：2
相关论文
共 50 条
  • [1] Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
    Massenkeil, G
    Rackwitz, S
    Genvresse, I
    Rosen, O
    Dörken, B
    Arnold, R
    BONE MARROW TRANSPLANTATION, 2002, 30 (12) : 899 - 903
  • [2] Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
    G Massenkeil
    S Rackwitz
    I Genvresse
    O Rosen
    B Dörken
    R Arnold
    Bone Marrow Transplantation, 2002, 30 : 899 - 903
  • [3] Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation
    Park, Joo Han
    Lee, Hyo Jung
    Kim, Sei Rhan
    Song, Ga Won
    Lee, Seung Kyong
    Park, Sun Young
    Kim, Ki Chan
    Hwang, Sun Hyuk
    Park, Joon Seong
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2014, 29 (05): : 630 - 636
  • [4] Basiliximab (Simulect®) for the treatment of steroid-resistant graft-versus-host-disease (GvHD) after nonmyeldablative allogeneic hematopoietic stem cell transplantation (HSCT).
    Ciceri, F
    Bernardi, M
    Peccatori, J
    Montefusco, V
    Guggiari, E
    Callegaro, L
    Corti, C
    Pescarollo, A
    Corradini, P
    Bregni, M
    BLOOD, 2002, 100 (11) : 441B - 441B
  • [5] Basiliximab in the treatment of acute graft-versus-host disease after allogeneic stem cell transplantation.
    Ma, X
    Wu, DP
    Sun, AN
    BLOOD, 2005, 106 (11) : 426B - 426B
  • [6] ETANERCEPT FOR STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Park, J. S.
    Jeong, S. H.
    Ahn, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S347 - S347
  • [7] Basiliximab Treatment for Patients With Steroid-Refractory Acute Graft-Versus-Host Disease Following Matched Sibling Donor Hematopoietic Stem Cell Transplantation
    Jiang, Xin-Ya
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Wang, Yu
    Yan, Chen-Hua
    Chen, Huan
    Chen, Yu-Hong
    Han, Wei
    Wang, Feng-Rong
    Wang, Jing-Zhi
    Sun, Yu-Qian
    Mo, Xiao-Dong
    Huang, Xiao-Jun
    CELL TRANSPLANTATION, 2024, 33
  • [8] Immune reconstitution following basiliximab treatment for steroid-refractory acute graft-versus-host disease after haploidentical hematopoietic stem cell transplantation
    Deng, D. -X.
    Fan, S.
    Shen, M. -Z.
    Zhang, X. -H.
    Xu, L. -P.
    Wang, Y.
    Yan, C. -H.
    Chen, H.
    Chen, Y. -H.
    Han, W.
    Wang, F. -R.
    Wang, J. -Z.
    Liu, K. -Y.
    Huang, X. -J.
    Mo, X. -D.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 310 - 310
  • [9] Basiliximab is well Tolerated and Effective in the Treatment of Steroid-Refractory Acute Gut Graft-Versus-Host Disease After Pediatric Allogeneic Stem Cell Transplantation
    Ansari, F.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S217 - S217
  • [10] Mesenchymal stem cells for the treatment of steroid refractory graft versus host disease after allogeneic stem cell transplantation
    Lysak, D.
    Holubova, M.
    Karas, M.
    Hrabetova, M.
    Steinerova, K.
    Jindra, P.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S224 - S225
12345